Clorox Company (CLX)

211.03
0.32 0.15
NYSE
Prev Close 211.35
Open 209.07
Day Low/High 206.05 / 211.49
52 Wk Low/High 144.31 / 239.87
Volume 697.52K
Exchange NYSE
Shares Outstanding 126.03B
Market Cap 26.54B
P/E Ratio 28.62
Div & Yield N.A. (N.A)
Jim Cramer: It Took Some Scrubbing, but I've Found a Bull Market

Jim Cramer: It Took Some Scrubbing, but I've Found a Bull Market

If you want to clean up, then look at the hygiene trend -- and these numbers from Reckitt Benckiser and Procter & Gamble.

Clorox Cut to Neutral at JPMorgan

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Covid Surges, Playing Politics, Charting the Nasdaq and S&P 500, U.S. Outlook

Markets have certainly recovered nicely off of the lows of late September. Now, here in mid-October, it feels like it did that cold night back in 1980-something. The wolves are visible and noisy.

You Can Get Hurt Falling From High Places

You Can Get Hurt Falling From High Places

Beware of high-flying stocks and instead opt for these 'grounded' ones.

Jim Cramer: Here's Why Apple and Tesla Are So High

Jim Cramer: Here's Why Apple and Tesla Are So High

These big names are not smoke and mirrors, if you look at what they really do.

Jim Cramer: Follow the Lead of Elon Musk and Tim Cook: Split

Jim Cramer: Follow the Lead of Elon Musk and Tim Cook: Split

Both Apple and Tesla are chopping shares into pieces, which will let individual investors have a shot at buying them.

Jim Cramer: Buyers, It's Time to Look in the Mirror

Jim Cramer: Buyers, It's Time to Look in the Mirror

Blame the Fed? No. I'm reserving my wrath for the clueless buyers who appear to have taken a permanent intellectual summer vacation.

Jim Cramer: Clorox, Covid and Indecision on Packaged Goods Stocks

Jim Cramer: Clorox, Covid and Indecision on Packaged Goods Stocks

The whole group has run and the guidance from Clorox does show, more than anything, that nobody knows.

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Ozzy and I Don't Know, Hare-Raising Tale, Enter the Dog Days: Market Recon

Plus, Russia could provide a real-time clinical trial of a coronavirus vaccine.

Johnson & Johnson Is Poised (Again) for an Upside Breakout

Johnson & Johnson Is Poised (Again) for an Upside Breakout

In this market, winning stocks 'stick out like a sore thumb.'

Jim Cramer: Here's My Sore Thumb Index

Jim Cramer: Here's My Sore Thumb Index

This is how you can tell which camp is winning and which is losing in this time of Covid-contradiction.

Ad Boycott Can't Stop Facebook

Ad Boycott Can't Stop Facebook

How did it feel for traders who sold Facebook on news of the ad boycott? Like putting your hand on a hot stove.

Jim Cramer: Don't Expect a Return to Business as Usual

Jim Cramer: Don't Expect a Return to Business as Usual

As the Covid crisis goes on, you will see fewer retail options, less vibrant cities, shuttered restaurants and the big to get bigger.

Clorox Rated New Buy at DA Davidson

Jim Cramer: Stuck at Home Yet Still Hopeful? Then Lift the 'Barbell'

Jim Cramer: Stuck at Home Yet Still Hopeful? Then Lift the 'Barbell'

There are stocks for people who believe we're roaring back, those who are hiding out from the virus, and those fearing gloom and doom. But here are the ones I'd give a workout.

Will Investors Clean Up With Clorox?

Will Investors Clean Up With Clorox?

The disinfecting-wipe maker continues to rally strongly toward higher price targets.

Jim Cramer: 20 Stocks That Are Emblematic of What's Driving the Market

Jim Cramer: 20 Stocks That Are Emblematic of What's Driving the Market

This list is not a buy list but a list of stocks that have been brought to new heights.

Jim Cramer: A Guide to the Great Pandemic of 2020

Jim Cramer: A Guide to the Great Pandemic of 2020

Disinfectant makers, home repair retailers and even camping equipment names might be your best bet until a vaccine comes.

Fibocall: Trading Technical Texts

Want to Know Why I'm Not Selling Moderna?

Want to Know Why I'm Not Selling Moderna?

I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.

Clorox Climbs and Could Clean Up Even More in the Months Ahead

Clorox Climbs and Could Clean Up Even More in the Months Ahead

Trading volume in the disinfectant maker's shares has been very active since February, which coincides with rising coronavirus fears.

Clorox Cleans Up

Clorox Cleans Up

Here's what I think about CLX shares.

Markets Test Support Levels, Amazon Earnings, Calibrating for Covid-19

Markets Test Support Levels, Amazon Earnings, Calibrating for Covid-19

The market sold off on Thursday after close as big hitters, including Amazon, reported earnings.

Shares of Clorox Could Fade Some in the Short-Term

Shares of Clorox Could Fade Some in the Short-Term

I would recommend raising stop protection to lock in some gains.

My New Multi-Group Portfolio Strategy for Trading the Pandemic

My New Multi-Group Portfolio Strategy for Trading the Pandemic

How has my book evolved since the Fed and Treasury rode into town? Here's how.

These 2 Stocks Should Easily Withstand the Economic Impacts of Covid-19

These 2 Stocks Should Easily Withstand the Economic Impacts of Covid-19

DropBox and BioDelivery Sciences are names to consider during the market choppiness of the coming weeks.

A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups

A Look at Our Situation Now: Good, Bad, and Ugly, and 3 New Stock Groups

Consider these stock model ideas: virus groups, work remotely, and fiscal.

Jim Cramer: What Can't Covid-19 Stop? The Cloud

Jim Cramer: What Can't Covid-19 Stop? The Cloud

It's a paradigm shift that all started with Zoom and Cisco's Webex.

Here's My Watchlist of 12 Covid-19 Stock Plays

Here's My Watchlist of 12 Covid-19 Stock Plays

If this group begins to outperform, then I'd use it as an indication of caution.

Jim Cramer: Every Bull Has Its Day

Jim Cramer: Every Bull Has Its Day

Science and ingenuity will prove the doomsday crowd wrong.